NEW YORK, Aug. 2, 2024 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in UiPath, Inc. (“UiPath” or the “Company”) (NYSE: PATH) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of UiPath investors who were adversely affected by…
Month: August 2024
NEW YORK, Aug. 2, 2024 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in CAE Inc. (“CAE” or the “Company”) (NYSE: CAE) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of CAE investors who were adversely affected by alleged…
NEW YORK, Aug. 2, 2024 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in CAE Inc. (“CAE” or the “Company”) (NYSE: CAE) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of CAE investors who were adversely affected by alleged…
LOS ANGELES, Aug. 2, 2024 /PRNewswire/ — The world’s biggest sports event in Paris is in full swing, igniting the passion of sports fans worldwide. But what if you could capture that same competitive spirit and win amazing prizes, all while cheering on your favorite athletes? Get ready…
BCC Research Study Projects 7.8% CAGR, with Market Growth from $1.5 Billion in 2024 to $2.1 Billion by 2029 BOSTON, Aug. 2, 2024 /PRNewswire/ — According to the latest BCC Research study, the demand for “In Vitro Diagnostics (IVD) Quality Controls: Global Market” is expected to grow from…
BOSTON, 2. August 2024 /PRNewswire/ — Kürzlich haben Shanghai Medicilon Inc. („Medicilon”) und Jiangsu Hengrui Pharmaceuticals Co., Ltd. („Hengrui Pharma”) eine strategische Zusammenarbeit vereinbart. Der Schwerpunkt der Zusammenarbeit liegt auf der präklinischen Bewertung von neuen…
BOSTON, 2 août 2024 /PRNewswire/ –Shanghai Medicilon Inc. (« Medicilon ») et Jiangsu Hengrui Pharmaceuticals Co., Ltd. (« Hengrui Pharma ») ont récemment conclu un accord de collaboration stratégique. Les efforts de coopération se concentreront sur l’évaluation préclinique de nouvelles…
-Medicilon y Hengrui Pharma profundizan la colaboración estratégica para apoyar la innovación en ADC, ácidos nucleicos pequeños y fármacos CGT BOSTON, 2 de agosto de 2024 /PRNewswire/ — Recientemente, Shanghai Medicilon Inc. (“Medicilon”) y Jiangsu Hengrui Pharmaceuticals Co., Ltd….
DONGYANG, China, 2 de agosto de 2024 /PRNewswire/ — Los módulos de la serie Infinity RT de DMEGC Solar llegan a la cima en la categoría de tecnología de módulos TOPCon en la lista de los mejores módulos de TaiyangNews – All About Solar de julio de 2024, ocupando el sexto lugar entre…
DONGYANG, China, 2. August 2024 /PRNewswire/ — Die Module der Infinity RT-Serie von DMEGC Solar stehen in der TOPCon-Modultechnologie-Kategorie in der Liste der Top-Module von TaiyangNews – All About Solar Juli 2024 an der Spitze und rangieren unter allen Modulen auf dem 6. Diese…